'Last resort' antibiotics increasingly used to fight multidrug-resistant bugs

Multidrug-resistant pathogens are becoming more frequent, and the few "last resort" treatments available for infections with these bacteria have also shown an increase in use in recent years, according to a study published May 16 in the open access journal PLoS ONE.

The authors, led by Makoto Jones of the Veterans Affairs Salt Lake City , investigated the use of two such antibiotics, polymyxins and tigecycline, in 127 Veterans Affairs medical centers between 2005 and 2010. They found that the overall use of these treatments was quite low, but that it did increase over the course of the study period. While this is the first study assessing use of these drugs in the United States on a large scale the trend is almost certainly not limited to the VA.

They also found that just eight facilities accounted for three quarters of all polymyxin use, and 26 facilities accounted for three quarters of all tigecycline use. Dr. Jones commented "The use of polymyxins, a class of relatively toxic antibiotics, has been increasing over time and appears to be a marker of very . To address this potential harbinger of a growing epidemic, a clear strategy of infection control, antibiotic development, and antibiotic stewardship will be necessary."

More information: Huttner B, Jones M, Rubin MA, Neuhauser MM, Gundlapalli A, et al. (2012) Drugs of Last Resort? The Use of Polymyxins and Tigecycline at US Veterans Affairs Medical Centers, 2005. PLoS ONE 7(5): e36649. doi:10.1371/journal.pone.0036649

add to favorites email to friend print save as pdf

Related Stories

'Last resort' antibiotics use on the rise, study shows

Apr 03, 2011

A large, multi-year study of antibiotic use in Veterans Health Administration's acute care facilities demonstrates dramatically increased use of carbapenems, a powerful class of antibiotics, over the last five years. These ...

Nanotechnology used to probe effectiveness of antibiotics

Feb 04, 2009

A group of researchers led by scientists from the London Centre for Nanotechnology, in collaboration with a University of Queensland researcher, have discovered a way of using tiny nano-probes to help understand how an antibiotic ...

Small amounts of antibiotics generate big problems

Jul 22, 2011

New research conducted at Uppsala University shows that extremely low concentrations of antibiotics can enrich for antibiotic resistant bacteria. The research suggests that antibiotic residue introduced to the environment ...

Antibiotic use increases at academic medical centers

Nov 10, 2008

Antibacterial drug use appears to have increased at academic medical centers between 2002 and 2006, driven primarily by greater use of broad-spectrum agents and the antibiotic vancomycin, according to a report in the Nov. ...

Recommended for you

Determine patient preferences by means of conjoint analysis

Jul 29, 2014

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

User comments